Largest health care biotech companies by earnings
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Gilead Sciences leads the 24 health care biotech companies ranked by earnings, at TRY 429.4B, ahead of Amgen (TRY 389.1B) and Biogen (TRY 65.2B). Figures as of 19 Nov 2026, 18:05 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 24
- First
- Gilead SciencesTRY 429.4B
- Median
- -TRY 3.5B
- Combined market value
- TRY 42.03T
- Countries
- 5
Market values as of .
All countries▾
Health Care▾
Biotech▾
| # | Company | Earnings ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Gilead SciencesGILD · Health Care | TRY 429.4B | TRY 10.48T | TRY 8,447.34 | 0.93% down | 35% up | ||
| 2 | AmgenAMGN · Health Care | TRY 389.1B | TRY 12.01T | TRY 22,212.04 | 0.83% down | 32% up | ||
| 3 | BiogenBIIB · Health Care | TRY 65.2B | TRY 1.84T | TRY 12,448.73 | 1.87% down | 49% up | ||
| 4 | argenxARGX · Health Care | TRY 65.2B | TRY 3T | TRY 47,643.86 | 0.31% up | 2% up | ||
| 5 | ExelixisEXEL · Health Care | TRY 39.5B | TRY 813.4B | TRY 3,333.32 | 3.27% down | 63% up | ||
| 6 | Neurocrine BiosciencesNBIX · Health Care | TRY 24.1B | TRY 804.5B | TRY 7,947.79 | 3.29% down | 17% up | ||
| 7 | QiagenQGEN · Health Care | TRY 21.4B | TRY 515.8B | TRY 2,497.97 | 0.11% down | 9% up | ||
| 8 | Halozyme TherapeuticsHALO · Health Care | TRY 16B | TRY 531.7B | TRY 4,663.42 | 3.53% down | 39% up | ||
| 9 | Krystal BiotechKRYS · Health Care | TRY 10.3B | TRY 474.4B | TRY 16,008.61 | 0.61% up | 54% up | ||
| 10 | Bio-TechneTECH · Health Care | TRY 9.2B | TRY 576.3B | TRY 3,668.87 | 0.05% down | 24% up | ||
| 11 | RepligenRGEN · Health Care | TRY 2.5B | TRY 552.8B | TRY 8,647.41 | 0.75% down | 12% up | ||
| 12 | Adaptive BiotechnologiesADPT · Health Care | -TRY 3B | TRY 234.6B | TRY 1,449.18 | 0.91% up | 74% up | ||
| 13 | Twist BioscienceTWST · Health Care | -TRY 3.9B | TRY 404.2B | TRY 5,928.93 | 0.99% up | 346% up | ||
| 14 | CG OncologyCGON · Health Care | -TRY 8.1B | TRY 369.5B | TRY 4,136.37 | 2.47% up | 97% up | ||
| 15 | Kodiak SciencesKOD · Health Care | -TRY 11.6B | TRY 324.8B | TRY 4,966.68 | 0.63% up | 399% up | ||
| 16 | Kymera TherapeuticsKYMR · Health Care | -TRY 15.7B | TRY 521.3B | TRY 6,106.54 | 0.09% down | 87% up | ||
| 17 | ImmunityBioIBRX · Health Care | -TRY 17.7B | TRY 354B | TRY 332.78 | 1.57% down | 232% up | ||
| 18 | Scholar Rock HoldingSRRK · Health Care | -TRY 19.1B | TRY 310.5B | TRY 2,544.65 | 5.06% up | 26% up | ||
| 19 | ImmunovantIMVT · Health Care | -TRY 25.5B | TRY 341.9B | TRY 1,652.03 | 1.30% down | 46% up | ||
| 20 | CRISPR TherapeuticsCRSP · Health Care | -TRY 29.3B | TRY 194.1B | TRY 2,000.95 | 1.33% down | 18% down | ||
| 21 | VaxcytePCVX · Health Care | -TRY 38.7B | TRY 473.5B | TRY 2,991.21 | 1.30% up | 23% up | ||
| 22 | Revolution MedicinesRVMD · Health Care | -TRY 57.1B | TRY 1.76T | TRY 8,152.66 | 1.09% up | 129% up | ||
| 23 | BioNTechBNTX · Health Care | -TRY 63.6B | TRY 1.02T | TRY 4,107.36 | 2.23% down | 14% down | ||
| 24 | ModernaMRNA · Health Care | -TRY 142.4B | TRY 4.12T | TRY 10,185.90 | 2.58% up | 780% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Earnings is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 50.4590 TRY).
Questions and answers
Which health care biotech companies rank first by earnings?
Gilead Sciences (TRY 429.4B), Amgen (TRY 389.1B) and Biogen (TRY 65.2B) are the top three of the 24 health care biotech companies ranked by earnings as of 19 Nov 2026, 18:05 UTC.
How many health care biotech companies are in this ranking?
24 are ranked by earnings.
What are these health care biotech companies worth together?
The 24 health care biotech companies ranked by earnings have a combined market value of TRY 42.03T as of 19 Nov 2026, 18:05 UTC.
What does ranking by earnings measure?
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest health care biotech companies by earnings”, data as of 19 November 2026. https://funkfolio.com/companies/category/biotech?sector=health-care&by=earnings
Underlying data: Yahoo Finance; SEC EDGAR.